These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17724495)

  • 21. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
    Ruiz-Palacios GM; Pérez-Schael I; Velázquez FR; Abate H; Breuer T; Clemens SC; Cheuvart B; Espinoza F; Gillard P; Innis BL; Cervantes Y; Linhares AC; López P; Macías-Parra M; Ortega-Barría E; Richardson V; Rivera-Medina DM; Rivera L; Salinas B; Pavía-Ruz N; Salmerón J; Rüttimann R; Tinoco JC; Rubio P; Nuñez E; Guerrero ML; Yarzábal JP; Damaso S; Tornieporth N; Sáez-Llorens X; Vergara RF; Vesikari T; Bouckenooghe A; Clemens R; De Vos B; O'Ryan M;
    N Engl J Med; 2006 Jan; 354(1):11-22. PubMed ID: 16394298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
    Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
    Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines Mexico City, Mexico, 8-9 February 2005.
    Wood D;
    Vaccine; 2005 Dec; 23(48-49):5478-87. PubMed ID: 16129525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spotlight on pentavalent rotavirus vaccine (RotaTeq) in the prevention of rotavirus gastroenteritis in Europe.
    Plosker GL
    BioDrugs; 2010 Dec; 24(6):411-4. PubMed ID: 21043548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotavirus vaccination: a concise review.
    Vesikari T
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():57-63. PubMed ID: 22882248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines.
    Lepage P; Vergison A
    Expert Opin Biol Ther; 2007 Dec; 7(12):1881-92. PubMed ID: 18034653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotavirus vaccines: recent developments and future considerations.
    Angel J; Franco MA; Greenberg HB
    Nat Rev Microbiol; 2007 Jul; 5(7):529-39. PubMed ID: 17571094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
    Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
    Pawinski R; Debrus S; Delem A; Smolenov I; Suryakiran PV; Han HH
    J Infect Dis; 2010 Sep; 202 Suppl():S80-6. PubMed ID: 20684722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine.
    Grant L; Watt J; Moulton L; Weatherholtz R; Reid R; Santosham M; O'Brien K
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):635-40. PubMed ID: 23343932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1999 Mar; 48(RR-2):1-20. PubMed ID: 10219046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rotarix: a rotavirus vaccine for the world.
    Ward RL; Bernstein DI
    Clin Infect Dis; 2009 Jan; 48(2):222-8. PubMed ID: 19072246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rotavirus vaccines: an overview.
    Dennehy PH
    Clin Microbiol Rev; 2008 Jan; 21(1):198-208. PubMed ID: 18202442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.
    Linhares AC; Velázquez FR; Pérez-Schael I; Sáez-Llorens X; Abate H; Espinoza F; López P; Macías-Parra M; Ortega-Barría E; Rivera-Medina DM; Rivera L; Pavía-Ruz N; Nuñez E; Damaso S; Ruiz-Palacios GM; De Vos B; O'Ryan M; Gillard P; Bouckenooghe A;
    Lancet; 2008 Apr; 371(9619):1181-9. PubMed ID: 18395579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life.
    Kawamura N; Tokoeda Y; Oshima M; Okahata H; Tsutsumi H; Van Doorn LJ; Muto H; Smolenov I; Suryakiran PV; Han HH
    Vaccine; 2011 Aug; 29(37):6335-41. PubMed ID: 21640780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A short report on highlights of world-wide development of RIX4414: an European experience.
    Vesikari T; Karvonen A; Puustinen L; Szakal ED; Zeng SQ; Delem A; De Vos B
    Vaccine; 2006 May; 24(18):3779. PubMed ID: 16581159
    [No Abstract]   [Full Text] [Related]  

  • 40. Rotavirus infection and the current status of rotavirus vaccines.
    Chen SC; Tan LB; Huang LM; Chen KT
    J Formos Med Assoc; 2012 Apr; 111(4):183-93. PubMed ID: 22526206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.